Effects of Artificial Intelligence Assisted Follow-up Strategy Based on a New Remote Contactless Sleep Monitoring System on Secondary Prevention in Patients Received Coronary Artery Bypass Grafting Surgery
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Heart rate
研究概览
简要总结
The present study is trying to find out whether artificial intelligence assisted follow-up strategy will improve secondary prevention in CABG patients. In addition, we will test whether rural patients may have more benefits under the new follow-up strategy based on the artificial intelligence device compared with urban patients.
详细描述
There are a large population of coronary heart disease patients in China, which needs more attention to optimize the secondary prevention and improve the prognosis. Secondary prevention has been showing the effects of improving symptoms, preventing disease progression, improving prognosis, and reducing mortality in patients received coronary artery bypass grafting (CABG) surgery. In this study, we are trying to evaluate the effectiveness of artificial intelligence (AI) assisted follow-up strategy on secondary prevention for patients received CABG surgery. And we are trying to find out whether there is difference in secondary prevention of coronary heart disease between urban and rural patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age between 18-70, male or female
- •Received isolated CABG procedure due to coronary artery disease
- •Having a smartphone and are willing to cooperate
- •Signing written informed consent
排除标准
- •Patients undergoing CABG + valve replacement surgery
- •Postoperative hospital stays more than 10 days (Due to limited postoperative follow-up time and unstable condition such as incision infection, angina, etc.)
- •Patients with lung, liver, and kidney failure (Due to organ dysfunction which needs more professional health care and not suitable for this trial)
- •Patients with Urinary system diseases (Getting up during sleep, which will interfere with sleep monitoring)
- •Patients mentally or legally disabled
- •Breastfeeding or pregnant women
- •End-stage disease, estimated survival time is less than 3 months
- •Participate in other perioperative intervention studies at the same time
结局指标
主要结局
Heart rate
时间窗: 35 days
The average heart rate during the first 35 days postoperatively
次要结局
- Minimum pulse oxygen saturation(35 days)
- Pain score(35 days)
- All-cause mortality(35 days)
- Duration of different sleep stages(35 days)
- Average Pulse oxygen saturation(35 days)
- Medication compliance(35 days)
- Re-admission rate(35 days)
- Total cost of medical expenses(35 days)
研究者
SHI Jia
Deputy director of the anesthesia center
Chinese Academy of Medical Sciences, Fuwai Hospital